Cellebrite files Form 144 to sell 282,905 shares

Cellebrite DI Ltd. filed a Rule 144 notice to sell 282,905 ordinary shares.

Rhea-AI Filing Summary

Cellebrite DI Ltd. filed a Rule 144 notice to sell 282,905 ordinary shares. The shares are described as Restricted Share Units vested under an issuer S-8 registered plan and the filing lists Morgan Stanley Smith Barney LLC as the broker. The filing shows dates 07/01/2026 and 07/02/2026.

Insights

Securities Counsel

Rule 144 notice for sale of vested RSUs, broker listed.

The filing lists 282,905 shares as restricted share units that vested under an S-8 plan and names Morgan Stanley Smith Barney LLC as the executing broker. Rule 144 notices disclose intended resale by control/affiliated holders and permit brokered market transactions once conditions are met.

Timing and final sale execution are not stated; subsequent SEC or broker disclosures would show actual sale details.

Key Figures

Shares to be resold: 282,905 shares Filing dates: 07/01/2026 and 07/02/2026 Numeric figure listed: 249,439,817

3 metrics

Shares to be resold 282,905 shares Restricted Share Units vested under an issuer S-8 registered plan (07/01/2026)

Filing dates 07/01/2026 and 07/02/2026 Dates shown in the Form 144 excerpt

Numeric figure listed 249,439,817 Numeric value appearing in the excerpt (label not explicit in provided text)

Key Terms

Restricted Share Units (RSUs), S-8 registered plan, Rule 144

3 terms

Restricted Share Units (RSUs) financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

S-8 registered plan regulatory

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Rule 144 regulatory

"Filer Information | Securities To Be Sold | Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLBT Form 144 report show?

It reports a proposed resale of 282,905 ordinary shares as RSUs vested under an S-8 plan. The filing names Morgan Stanley Smith Barney LLC as the broker and includes dates 07/01/2026 and 07/02/2026.

Are the 282,905 shares part of compensation or open market holdings for CLBT?

They are described as Restricted Share Units vested under an issuer S-8 registered plan, indicating compensation-origin shares that became eligible for resale under Rule 144.

Does the Form 144 indicate the sale is completed for CLBT?

No; the notice indicates an intended resale under Rule 144 but does not state that the shares have been sold. Execution details are not provided in the excerpt.

Who is listed as the broker on the CLBT Form 144 filing?

The filing lists Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker for the proposed resale of the shares on the filing dates shown.

Does the filing state how many shares outstanding CLBT has?

The excerpt includes 249,439,817 as a numeric figure alongside filing details, but it does not explicitly label that number as shares outstanding within the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 07:34 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002013619
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972-73-394-8000
Name of Person for Whose Account the Securities are To Be Sold	Thomas E. Hogan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director and Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	282905	4011593	249439817	07/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	07/01/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	CELLEBRITE DI LTD.			282905	07/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The reporting person intends to sell the securities reported herein on 07/02/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	06/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Thomas E. Hogan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)